Wealth Alliance boosted its position in Lam Research Co. (NASDAQ:LRCX - Free Report) by 874.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,012 shares of the semiconductor company's stock after purchasing an additional 12,574 shares during the period. Wealth Alliance's holdings in Lam Research were worth $1,012,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Migdal Insurance & Financial Holdings Ltd. increased its stake in shares of Lam Research by 2,400.0% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 200 shares of the semiconductor company's stock valued at $163,000 after buying an additional 192 shares during the period. Insight Wealth Partners LLC acquired a new position in Lam Research in the 3rd quarter valued at approximately $202,000. B&L Asset Management LLC bought a new position in shares of Lam Research during the third quarter valued at $204,000. CWC Advisors LLC. acquired a new position in shares of Lam Research during the third quarter worth $220,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Lam Research in the third quarter worth $220,000. 84.61% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Lam Research
In related news, SVP Seshasayee Varadarajan sold 110,080 shares of the business's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $90.00, for a total transaction of $9,907,200.00. Following the transaction, the senior vice president now directly owns 179,084 shares in the company, valued at approximately $16,117,560. The trade was a 38.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.29% of the stock is owned by insiders.
Lam Research Stock Down 3.4 %
LRCX stock traded down $3.00 during midday trading on Friday, reaching $86.02. 12,857,061 shares of the company's stock traded hands, compared to its average volume of 12,447,650. Lam Research Co. has a 52 week low of $68.87 and a 52 week high of $113.00. The company has a market cap of $110.42 billion, a price-to-earnings ratio of 26.13, a P/E/G ratio of 1.45 and a beta of 1.46. The firm's fifty day moving average price is $78.27 and its 200-day moving average price is $77.97. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. As a group, sell-side analysts forecast that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.
Lam Research Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Wednesday, March 5th will be given a dividend of $0.23 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.92 annualized dividend and a dividend yield of 1.07%. Lam Research's payout ratio is 27.95%.
Analyst Ratings Changes
LRCX has been the topic of a number of analyst reports. Morgan Stanley upped their price target on Lam Research from $76.00 to $78.00 and gave the company an "equal weight" rating in a research report on Thursday, December 5th. Wolfe Research downgraded shares of Lam Research from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, January 15th. Stifel Nicolaus restated a "buy" rating and issued a $100.00 price target (down previously from $105.00) on shares of Lam Research in a research report on Thursday, October 24th. The Goldman Sachs Group decreased their price objective on shares of Lam Research from $96.00 to $85.00 and set a "buy" rating for the company in a research report on Friday, January 10th. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $100.00 target price on shares of Lam Research in a report on Tuesday. Six research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, Lam Research presently has a consensus rating of "Moderate Buy" and an average target price of $98.22.
Read Our Latest Research Report on Lam Research
Lam Research Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.